Stocks opened up on the day and stayed up on the day, despite closing well off of the highs. We had three key economic reports hit at once as the Institute for Supply Management gave the June ISM Manufacturing data, while we saw pending home sales data and new construction spending data mixed for May. These actually ended up being contradictory numbers, and then the oil inventories did nothing to support higher oil prices.

Here were today's unofficial closing bell levels:

Dow 8,504.06 +57.06 (0.68%)
S&P 500 923.33 +4.01 (0.44%)
Nasdaq 1,845.72 +10.68 (0.58%)

Top Analyst Upgrades & Downgrades

Here are some highlights from this past week's earnings coverage from BloggingStocks:

• Accenture Ltd. (NYSE: ACN) beat earnings expectations but revenue was hurt by currency effects.
• Bed Bath & Beyond Inc. (NASDAQ: BBBY) strong Q1 results beat estimates but same-store sales fell.
• CKE Restaurants Inc. (NYSE: CKR) lower Q1 earnings and strong sales both topped expectations.
• ConAgra Foods Inc. (NYSE: CAG) higher Q4 earnings were in line with expectations, and shares slipped.
• Darden Restaurants Inc. (NYSE: DRI) Q4 results were higher, but it warned of continuing challenges.
• Hennes & Mauritz (OTC: HMRZF) reported strong Q2 numbers, though same-stores sales slipped.

Rite Aid (NYSE: RAD), which competes with Walgreen (NYSE: WAG), CVS Caremark (NYSE: CVS), and Wal-Mart (NYSE: WMT), saw a big increase in volume on Wednesday after it reported earnings for the first quarter. In fact, as Douglas McIntyre observed, shares of Rite Aid were up 5% at one point during yesterday's session. However, the shares ended up losing their green status by the close of trading. Rite Aid actually lost 3% when all was said and done. What does it all mean?

Well, Rite Aid did beat analyst forecasts by a wide margin. The call was for a loss of 13 cents per share. Rite Aid lost only 6 cents per share once adjustments are made. Revenues dipped a little over 1%, and same-store sales, after excluding the effect of the Brooks Eckerd acquisition, increased 1.5%. Interestingly, the mix of this increase is as follows: the pharmacy sales went up 3.1% on a comparable basis, and the non-pharmacy sales went down 1.4% on the same basis.

Today was an unusually active day for extremely volume increases in several stocks which traded on news and rumors.

Shares in Sequenom (NASDAQ: SQNM) jumped over 10% on takevover rumors.

Rite Aide (NYSE: RAD) moved higher by 5% on larger than normal volume as it beat earnings estimates and Monsanto (NYSE: MON) traded up on strong numbers and took a number of agriculture stocks with it. Oracle (NASDAQ: ORCL) also benefited from earnings above Wall Street forecasts.

Palm (NASDAQ: PALM) traded higher as RBC upped its price target to $18 from $14, and MEMC (NYSE: WFR) fell on a downgrade from JPMorgan.

Douglas A. McIntyre is an editor at VSInvestor.com.

Walgreen (NYSE: WAG), a drugstore business that competes with CVS Caremark (NYSE: CVS) and Rite-Aid (NYSE: RAD), will be issuing results for the third quarter on Monday, June 22. According to Earnings.com, the analyst community is prescribing $0.56 per share for the company.

Of course, the question is: will Walgreen honor that prescription and fill it? I'd say it's quite possible. Last time around, Walgreen beat estimates. The call was for $0.66 per share in Q2. If you look at the press release from that time, you'll see that, once you adjust for some items, Walgreen went beyond expectations.

Here are some highlights from this past week's earnings coverage from BloggingStocks:

• American Electric Power Co. Inc. (NYSE: AEP) lowered its earnings forecast for fiscal 2009.
• Apollo Group Inc. (NASDAQ: APOL) reported better-than-expected Q2 earnings and strong revenue growth.
• Borders Group Inc. (NYSE: BGP) reported better-than-expected Q4 earnings despite a decline in sales.
• CarMax Inc. (NYSE: KMX) soaring earnings beat Q4 expectations despite a decline in revenue.
• Colgate-Palmolive Co. (NYSE: CL) was downgraded on risk to its earnings from currency issues.

Rite Aid (NYSE: RAD), whose competitors include Walgreen (NYSE: WAG), CVS Caremark (NYSE: CVS), and Wal-Mart (NYSE: WMT), reported Q4 numbers today, and when you read through the release, you sort of come away with a decent feeling. You hear about improvements in this metric and that metric. You wonder if a turnaround might be in the offing. Then you look at the stock price and, even though it is currently being bid higher (it's up over 14% as I write), you come back down to earth and reality hits you in the face. Anything trading under a buck has to give you pause. Rite Aid is no different.

For the quarter, Rite Aid posted a 1.7% decrease in the top line. On an adjusted basis, the drugstore chain reported a loss of $0.14 per share. According to this source, Wall Street thought Rite Aid might lose $0.105 per share. The company is still adjusting to the Brooks Eckerd acquisition. Excluding that effect, same-store sales increased 0.8%. Including the asset, comps decreased 0.1%.

Walgreen (NYSE: WAG ) knows that people want all kinds of options to meet their healthcare needs. Walgreen also knows that it needs to grow and keep up with competitor CVS Caremark (NYSE: CVS) and the pharmacy department at Wal-Mart (NYSE: WMT). And, yes, I suppose Rite-Aid (NYSE: RAD) is technically a competitor, too, although you wouldn't know it by that drugstore chain's stock price. Well, according to The Wall Street Journal, Walgreen plans to promote an initiative called "Complete Care and Well-Being" to employers. The goal here is to give corporate, as well as government, employees and their families access to healthcare services such as preventive medicine and dental examinations in off-hour time periods. Walgreen will use a network of in-store clinics and health centers to provide these services. That's pretty cool, right? Well, one of the bigger benefits to Walgreen is the synergy it can promote by leveraging this program.

The first trading session of the 2009 may have brought some optimism with it as markets rallied, but it's difficult to imagine all our troubles over after a year that set one bad and worse record after another. Stocks mirrored the global economic slowdown brought on by the housing market and the financial markets crises.

Still, there are many who still seek to invest in hope that one day they could get nice returns on their investments. While the recent volatility in the stock market benefited some shrewd day traders, most investors know to stick to a long-term, stable investment plan.

To help achieve some of these long-term return, BloggingStocks contributors continued to suggest some companies to invest in, as well as some to avoid:

Activision Blizzard (NASDAQ: ATVI) -- despite having his confidence in the stock shaken somewhat lately as sales may have been softer than expected, Steven Mallas is still bullish on the stock and feels it is attractive at these levels. Take-Two Interactive (NASDAQ: TTWO), however, "seems a little scary to be buying in now," he says.

It seems so astonishing that it can't be true, but there are experts who believe that 25% of American retailers could fail over the course of the next year or two. According to The Wall Street Journal (subscription required), "AlixPartners LLP, a Michigan-based turnaround consulting firm, estimates that 25.8% of 182 large retailers it tracks are at significant risk of filing for bankruptcy or facing financial distress in 2009 or 2010."

If an extremely large number of retailers do close, the job loss could be incredible. Troubled retailer Pier 1 (NYSE: PIR), which trades at $0.33, has more than 6,100 employees. Rite Aid (NYSE: RAD), which also trades at $0.33, has over 60,000. If several medium-sized to large store chains move into bankruptcy, hundreds of thousands of jobs will be at stake. This does not include more modest-sized operators.

The retail industry is critical to the American economy. If it falls apart rapidly, it helps put the recession into a deeper downward spiral. Retail employees lose jobs and then are no longer consumers. With fewer consumers, more retailers and other business fail. Tax income for municipal, state, and the federal governments is also undermined, putting pressure on government employment.

The jobless rate my be close to 7% now. The retail part of the economy could move that number up quite a bit all by itself.

Douglas A. McIntyre is an editor at 247wallst.com.

Walgreen (NYSE: WAG), a major drugstore chain whose enemies include CVS Caremark (NYSE: CVS) and Rite-Aid (NYSE: RAD), is getting ready to report earnings for its first fiscal quarter on Monday, December 22. It's Christmas week. Will Walgreen bestow a gift of an earnings beat upon the market?

One thing's for sure: the market does not expect much from the drugstore. Wall Street expects flat performance in Q1. The bottom line should come in somewhere around $0.46 per share, the exact same amount that was booked last year. You know, you figure the company should be able to at least match expectations when the bar is set so low. But it might be tough. We all need access to prescriptions and over-the-counter medications every now and then, and on top of that, many people obviously require long-term drug regimens. So, we can see that the pharmacy part of the equation is somewhat resistant to recession. However, there isn't a pressing need for all the non-pharmacy items in a Walgreen location. You don't need to buy any of those cheap plastic toys, any of those blenders that don't work too well, any of the overpriced groceries, etc. This is where Walgreen has exposure to the weakening consumer. Indeed, the consumer is becoming more and more of a value Grinch as time goes on. People just don't want to pay any more than they have to.

Here are some highlights from this past week's earnings coverage from BloggingStocks:

• Adobe Systems Inc. (NASDAQ: ADBE) posted strong Q4 and full-year results, but with flat Q4 revenues.
• Best Buy Inc. (NYSE: BBY) beat Q3 expectations though earnings tumbled, and shares rose about 18%.
• Carnival Corp. (NYSE: CCL) announced that it had lowered its full-year earnings and revenue guidance.
• Discover Financial Services (NYSE: DFS) net income from continuing operations more than doubled in Q4.
• Eaton Corp. (NYSE: ETN) cut its Q4 earnings guidance on weakness in the American auto market.
• FedEx Corp. (NYSE: FDX) Q2 earnings topped expectations and it reaffirmed its guidance.
• General Electric Co. (NYSE: GE) declined to provide quarterly earnings guidance in its annual outlook.
• General Mills (NYSE: GIS) posted a higher-than-expected profit on cost cutting and increased marketing.
• Gilead Sciences Inc. (NASDAQ: GILD) strong earnings growth are expected by one analyst to continue.
• Goldman Sachs Group (NYSE: GS) swung to an anticipated Q4 loss and reported negative revenues.
• Healthcare Realty Trust Inc. (NYSE: HR) was downgraded due to its near-term earnings prospects.
• Honeywell International Inc. (NYSE: HON) affirmed a lower 2009 outlook and said it expects profits to fall.

Rite-Aid Corporation (NYSE: RAD) is the drugstore you should avoid. You can consider CVS Caremark (NYSE: CVS). You can take a look at Walgreen Company (NYSE: WAG). Rite-Aid? It's definitely not the cure for an ailing portfolio.

The troubled pharmacy chain is no stranger to losses and its public stock sits well below a buck a share. The third quarter numbers don't look too appealing. On an adjusted basis, Rite-Aid lost $0.15 per share. That may have been better than what analysts were calling for, namely a loss of $0.17 per share, but you have to look at the overall picture. Rite-Aid is closing stores, and that will hamper sales going forward (not to mention its brand equity, as well). Some will argue that it's all part of the turnaround. Sure, turnarounds can be ugly and painful, granted, but that doesn't mean you have to participate, hoping for the best. Why hop on this low-priced equity when integration of the Brooks Eckerd assets doesn't seem to be going very well?

According to the press release, there are a few positive statistics. Management says that overall same-store sales were up 1.4%, EBITDA increased over 8%, and operational cash flow was positive over the last three quarters (by comparison, cash was used for operations in the year-ago similar period). But the guidance isn't good, and I have no confidence in this management team to improve its GAAP performance. The company has to juice its sales, but with competition from stronger foes like CVS Caremark and Walgreen, I just don't see any silver lining to the Rite-Aid story. Turnaround specialists can make whatever argument they want. As for me, I'm going to make like the galaxy in Star Wars and stay far, far away from Rite-Aid's stock...

Disclosure: I don't own any company mentioned; positions can change at any time.

Today's markets were mixed for most of the day, but the GE call from S&P accelerated selling pressure into the close. The markets failed to react to a decrease in the weekly jobless claims, and considerably lower oil prices of under $37 per barrel failed to cause a cheer. Here are the unofficial closing bell levels:
DJIA: 8,604.99 (-2.49%)
S&P500: 885.34 (-2.11%)
NASDAQ: 1,552.37 (-1.71%)

General Electric Co. (NYSE: GE) was one of the causes of today's sell-off after SD&P put the outlook down to negative from stable, although this was not a downgrade. GE was down 8% at $15.94 around the close.

General Motors Corp. (NYSE: GM) tanked after the Bush administration said it wanted to seek a solution by Christmas, but noted that it was considering a bailout plan that might be under an orderly Chapter 11 plan. Like there is such a thing. Shares were off by 15% at $3.70 before the close.

Rite Aid Corp. (NYSE: RAD) posted -$0.30 EPS on $6.47 billion in revenues vs. -$0.17 EPS and $6.46 billion revenue estimates. The company now sees a wider loss for fiscal Feb-2009 and lowered its same store sales expectations. This took shares down by 12% to $0.445 right before the close.

Take-Two Interactive Software Inc. (NASDAQ: TTWO) was a big loser after the company missed its earnings projections and severely lowered guidance for 2009. Shares were challenging 52-week lows and were down 26% at $8.89 right before the close.

Today's economic numbers looked just as we expect for some time: Horrible. University of Michigan sentiment and housing looked atrocious. Warren Buffett wrote a short piece in the New York Times calling it the time to buy stocks. Today was an options expiration date and that led to added volatility throughout the trading day. Below are today's unofficial closing bell levels:

DJIA 8,852.22 (-127.04; -1.41%)
NASDAQ 1,711.29 (-6.42; -0.37%)
S&P500 940.50 (-5.93; -0.63%)
10YR T-Bond 3.938% (+0.002%)
Top Analyst Upgrades

Gilead Sciences (NASDAQ: GILD) traded up marginally after beating earnings with $0.55 non-GAAP EPS vs. $0.49 estimates, but it did outline how currencies helped out its bottom line. Shares still managed to trade up today and shares were up 3% at $42.67 right before the close.